MNKD - Total Utang marang Modal Afrezza

Logo perusahaan publik MannKind Corporation (MNKD)

MannKind Corporation (MNKD) minimizes geopolitical risks through local production in the US, although it remains dependent on Asian components. The total debt-to-equity ratio demonstrates current financial stability with the metric at 0.00. The company achieved a breakthrough by creating inhaled powder insulin. The business is now seeking to overcome product dependency by introducing treatments for rare lung pathologies.

MNKD: Total Utang marang Modal MannKind 04.07.2022 - 31.10.2026
Barang utama Afrezza

The ratio is calculated as total liabilities divided by equity, making it sensitive to any changes in the liability structure. This metric determines the degree of financial leverage and the risk of the business's dependence on borrowed funds. For MannKind Corporation (MNKD), which utilizes outsourcing for production and logistics, this balance is critical for maintaining operational flexibility. Analyzing the company's debt leverage history allows for the timely identification of a dangerous increase in indebtedness. This trend warns investors against investing in a potentially insolvent asset.

Analisis pesaing MannKind Corporation

Utang marang Ekuitas Haleon|Kenvue Inc - Utang Agregat marang Ekuitas|Total Utang marang Modal VRNA|MENS (Jyong Bio) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal LGND (Ligand Pharmaceuticals)|Total Utang marang Modal amneal.com AMRX|PRGO - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ALVO (Alvotech S.A.)|Liquidia Technologies (LQDA) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Galapagos Corp|ANIP (ANI Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal amphastar.com|Rasio Total Utang marang Ekuitas PCRX (Pacira BioSciences, Inc.)|SPRY (ARS Pharmaceuticals Inc) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Theravance TBPH|Aquestive Corp (AQST) - Utang marang Modal|SCPH: Rasio Total Utang marang Ekuitas|Tectonic Therapeutic, Inc. - Utang Agregat marang Modal|TNXP: Total Utang marang Modal|China SXT Pharmaceuticals, Inc. - Rasio Kabeh Utang marang Dana Pribadi|EPRX (Eupraxia Pharmaceuticals, Inc.) - Total Utang marang Modal|Utang marang Modal BioHarvest Sciences Inc BHST|Utang marang Ekuitas eXoZymes Inc (EXOZ)|ORMP (oramed.com) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Entera Bio ENTX|HYFT - Rasio Total Utang marang Ekuitas|ABVC BioPharma Inc - Total Utang marang Modal|CPIX - Total Utang marang Modal|Quantum BioPharma Ltd (QNTM) - Utang marang Ekuitas|Rasio Utang marang Ekuitas FGEN|Utang marang Ekuitas Telomir Pharmaceuticals, Inc.|Rasio Utang marang Ekuitas RANI (Rani Therapeutics Inc)|Utang marang Ekuitas Synergy CHC Corp (SNYR)|Total Utang marang Modal rallybio.com (RLYB)|Total Utang marang Modal LEXX (Lexaria Bioscience Corp.)|Koefisien Total Utang marang Modal pulmatrix.com (PULM)|PTHL - Utang marang Ekuitas|APM (Aptorum Group Limited) - Rasio Utang marang Ekuitas|LYRA: Total Utang marang Modal|Rasio Utang marang Ekuitas IBO|Rasio Total Utang marang Ekuitas TNFA|YCBD: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PRFX|Rasio Total Utang marang Ekuitas altamiratherapeutics.com CYTO|Utang marang Ekuitas Lipella LIPO|OptiNose Corp (OPTN) - Utang marang Modal|PIRS - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi PROC (procapsgroup.com)|Petros Pharmaceuticals, Inc. (PTPI) - Utang marang Ekuitas|Utang Agregat marang Ekuitas QLI (Qilian International Holding Group)|Utang marang Ekuitas ACELYRIN, Inc.|Utang marang Modal TFF Pharmaceuticals, Inc TFFP